1 | Provisional Agenda | 26/07/2018 | | CX/NFSDU 18/40/1 |
9 | Documento de debate sobre VRN-N para los lactantes de más
edad y los niños pequeños | 09/10/2018 | | CX/NFSDU 18/40/10 |
6 | Anteproyecto de definición del bioenriquecimiento | 05/10/2018 | | CX/NFSDU 18/40/7 |
4.2 | Revisión de la Norma para preparados complementarios (CXS 156
– 1987) | 05/10/2018 | | CX/NFSDU 18/40/5 |
12 | Documento de debate sobre las directrices generales para el
establecimiento de perfiles de nutrientes | 14/09/2018 | | CX/NFSDU 18/40/13 |
11 | Documento de debate sobre las directrices armonizadas sobre el
uso de probióticos en alimentos y en complementos alimenticios | 25/10/2018 | | CX/NFSDU 18/40/12 |
8.1 | Anteproyecto de declaración de propiedades “libre de ácidos
grasos trans”
| 10/10/2018 | | CX/NFSDU 18/40/9 |
5 | Anteproyecto de directrices para los alimentos terapéuticos listos
para el consumo (ATLC) | 24/11/2018 | | CX/NFSDU 18/40/6 |
4 | Review of the Standard for Follow-up Formula: essential composition requirements | 09/10/2018 | | REP18/NFSDU Appendix II |
8 | Proposed draft Claim for “free” of Trans Fatty Acids | 27/09/2018 | | REP18/NFSDU Appendix VI |
7 | Anteproyecto de VRN-ENT para los ácidos grasos omega 3 de cadena larga: ácido eicosapentaenoico (EPA) y ácido docosahexaenoico (DHA | 19/10/2018 | | CX/NFSDU 18/40/8 |
2 | Cuestiones remitidas al Comité por la Comisión del Codex
Alimentarius y/o sus órganos auxiliares | 26/10/2018 | | CX/NFSDU 18/40/2 |
3 | Cuestiones de interés planteadas por la FAO y la OMS | 16/11/2018 | | CX/NFSDU 18/40/3 rev |
6.1 | Anteproyecto de definición del bioenriquecimiento - Observaciones en el trámite 3 | 07/11/2018 | | CX/NFSDU 18/40/7 Add.1 |
5.1 | Anteproyecto de directrices para los alimentos terapéuticos listos
para el consumo (ATLC) - observaciones | 22/11/2018 | | CX/NFSDU 18/40/6 Add.1 |
7.1 | Anteproyecto de VRN-ENT para los ácidos grasos omega 3 de cadena larga: ácido eicosapentaenoico (AEP) y ácido docosahexaenoico (ADH): observaciones | 20/11/2018 | | CX/NFSDU 18/40/8 Add.1 |
4.3 | Revisión de la Norma para preparados complementarios: ámbito de aplicación, definición del producto y etiquetado -
Observaciones en el trámite 3
| 22/11/2018 | | CX/NFSDU 18/40/5 Add.1 |
10 | Documento de debate sobre el mecanismo/marco para examinar
la justificación tecnológica de los aditivos alimentarios | 23/11/2018 | | CX/NFSDU 18/40/11 |
4.1 | Revisión de la norma para preparados complementarios: requisitos de composición esencial
Observaciones en el trámite 6 (respuestas a la circular CL 2018/62/OCS-NFSDU)
| 12/11/2018 | | CX/NFSDU 18/40/4 Rev |
107 | Proposal of options (prepared by the Chair of the EWG of the proposed draft claim for "Free" of TFAs) - item 8 | 16/11/2018 | | CRD7 |
112 | Comments of GOED on item 7 | 20/11/2018 | | CRD12 |
101 | Division of Competence between the European Union and its Member States | 22/11/2018 | | CRD1 |
128 | Report of the PWG on the proposed draft guidelines for RUTF | 25/11/2018 | | CRD28 |
| Informe | 11/01/2019 | | REP19/NFSDU |
0.1 | Information for delegates | 25/07/2018 | | |
102 | Proposal for new work on the general requirements for protein supplements intended for bodybuilding | 17/09/2018 | | CRD2 |
103 | Methods of analysis in the Standard for Infant Formula and Formulas for Special Medical Purposes Intended for Infants (CXS 72-1981) | 15/10/2018 | | CRD3 |
104 | Proposal for new work on International Prebiotic Guidelines for Use in Foods and Dietary Supplements | 15/11/2018 | | CRD4 |
105 | Editorial and technical amendments to the Essential Composition Requirements for Follow-up Formula for older infants and [Name of Product] for young children (Prepared by the Chair of the EWG of the review of the Standard for Follow-Up Formula) - item 4a | 16/11/2018 | | CRD5 |
0.2 | Information about the German Team for CCNFSDU40 | 16/11/2018 | | |
106 | Comments of ISDI on item 4a | 16/11/2018 | | CRD6 |
108 | Comments of CRN on CRD2 | 16/11/2018 | | CRD8 |
12.1 | Comments of Iran, Kenya on item 12 | 16/11/2018 | | CX/NFSDU 18/40/13 Add.1 |
9.1 | Comments of Kenya, ISDI on item 9 | 16/11/2018 | | CX/NFSDU 18/40/10 Add.1 |
8.2 | Comments of Kenya, Malaysia, IFMA on item 8 | 16/11/2018 | | CX/NFSDU 18/40/9 Add.1 |
6.2 | Comments of Kenya, Nicaragua and FoodDrinkEurope on item 6 | 16/11/2018 | | CX/NFSDU 18/40/7 Add.2 |
4.15 | Comments of Egypt, European Union, Singapore, United States, Vietnam on item 4a | 16/11/2018 | | CX/NFSDU 18/40/4 Add.1 |
4.4 | Comments of Kenya, Lao People Democratic Republic on item 4b | 16/11/2018 | | CX/NFSDU 18/40/5 Add.2 |
5.2 | Comments of Canada and United States on item 5 | 16/11/2018 | | CX/NFSDU 18/40/6 Add.2 |
11.1 | Comments of Kenya, CRN, IADSA, IDF, IPA on item 11 | 16/11/2018 | | CX/NFSDU 18/40/12 Add.1 |
0.3 | Report of the FAO Expert Working Group: Protein quality assessment in follow-up formula for young children and read to use therapeutic foods | 20/11/2018 | | |
109 | Protein quality requirements for [Name of product] for young children (Prepared by the Chair of the EWG of the review of the Standard for Follow-Up Formula) - item 4b | 20/11/2018 | | CRD9 |
110 | Comments of EU on item 5 | 20/11/2018 | | CRD10 |
111 | Comments of NHF on item 6 | 20/11/2018 | | CRD11 |
113 | Comments of ISDI on item 10 | 20/11/2018 | | CRD13 |
114 | Comments of Thailand on items 4a, 4b, 5, 6, 8, 9, 10 and CRD 3 | 21/11/2018 | | CRD14 |
115 | Comments of IACFO on item 4b | 21/11/2018 | | CRD15 |
116 | Revised guidelines (prepared by the chair of the EWG on RUTF) - item 5 | 21/11/2018 | | CRD16 |
117 | Comments of Philippines on item 5 | 21/11/2018 | | CRD17 |
118 | Comments of EU and IACFO on item 6 | 21/11/2018 | | CRD18 |
119 | Comments of ISDI on CRD 3 | 21/11/2018 | | CRD19 |
120 | Reply from WHO in response to the request for advice on establishing NRV-NCD for EPA and DHA - item 7 | 21/11/2018 | | CRD20 |
121 | Comments of Egypt on item 5 | 22/11/2018 | | CRD21 |
123 | Comments of India on item 4a and 5 | 22/11/2018 | | CRD23 |
124 | Comments of EFLA on item 4b | 22/11/2018 | | CRD24 |
122 | TORs for a possible 2019 EWG (prepared by the Chairs of the EWG of NRV-R for older infants and young children) item 9 | 22/11/2018 | | CRD22 |
125 | Comments of the African Union on the items 2, 4b, 5, 6, 7, 8, 9, 11 and 12 | 23/11/2018 | | CRD25 |
126 | Comments of Morocco on items 4b, 6, 8, 11 and 12 | 23/11/2018 | | CRD26 |
0.4 | Expert advice on appropriate criteria and limits for contaminants in RUTF (UNICEF -WFP) | 23/11/2018 | | |
127 | Comments of Nigeria on item 1, 2, 4b and 5 | 25/11/2018 | | CRD27 |
129 | Comments o the Russian Federation on items 4a, 4b, 5, 6, 7, 8, 9, 10, 11 and 12 | 25/11/2018 | | CRD29 |
130 | Comments of Sudan on CRD4 | 26/11/2018 | | CRD30 |
131 | Comments of Mexico on item 4b | 26/11/2018 | | CRD31 |
132 | Comments of the Republic of korea on items 4b and 8 | 26/11/2018 | | CRD32 |
134 | Report of the in-session WG on the Mechanism/framework for considering the technological justification of food additives (item 10) | 28/11/2018 | | CRD34 |
133 | Report of the in-session WG on the Methods of analysis in CXS 72-1981) | 28/11/2018 | | CRD33 |
135 | Additional Information of WHO activities on alcohol (item 3) | 28/11/2018 | | CRD35 |
136 | Comments of Indonesia on items 2, 5, 9, 11, 12, CRD2 and CRD3 | 28/11/2018 | | CRD36 |
137 | Comments of El Salvador on items 6, 8, 12 | 28/11/2018 | | CRD37 |
138 | All files zip collection | | | |